BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review

March 2021 | 55 pages | ID: B3919CB53B4EN
GlobalData

Abstracts

BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company that develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.

BioDelivery Sciences International Inc Key Recent Developments

Feb 11,2021: BioDelivery Sciences CFO Terry Coelho promoted to Executive Vice President
Nov 05,2020: BioDelivery Sciences reports strong Q3 2020 results
Nov 04,2020: BioDelivery Sciences announces appointment of Jeff Bailey as permanent CEO
Aug 05,2020: BioDelivery Sciences reports strong q2 2020 results
May 11,2020: BioDelivery Sciences appoints Jeff Bailey interim CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

BioDelivery Sciences International Inc - Key Facts
BioDelivery Sciences International Inc - Key Employees
BioDelivery Sciences International Inc - Key Employee Biographies
BioDelivery Sciences International Inc - Major Products and Services
BioDelivery Sciences International Inc - History
BioDelivery Sciences International Inc - Company Statement
BioDelivery Sciences International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
BioDelivery Sciences International Inc - Business Description
Business Segment: Contract Revenue
Overview
Performance
Business Segment: Product Royalty Revenue
Overview
Performance
Business Segment: Product Sales
Overview
Performance
BioDelivery Sciences International Inc - Corporate Strategy
BioDelivery Sciences International Inc - SWOT Analysis
SWOT Analysis - Overview
BioDelivery Sciences International Inc - Strengths
BioDelivery Sciences International Inc - Weaknesses
BioDelivery Sciences International Inc - Opportunities
BioDelivery Sciences International Inc - Threats
BioDelivery Sciences International Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioDelivery Sciences International Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 11, 2021: BioDelivery Sciences CFO Terry Coelho promoted to Executive Vice President
Nov 05, 2020: BioDelivery Sciences reports strong Q3 2020 results
Nov 04, 2020: BioDelivery Sciences announces appointment of Jeff Bailey as permanent CEO
Aug 05, 2020: BioDelivery Sciences reports strong q2 2020 results
May 11, 2020: BioDelivery Sciences appoints Jeff Bailey interim CEO
May 07, 2020: BioDelivery Sciences reports strong Q1 2020 results
Mar 12, 2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
Mar 09, 2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
Jan 13, 2020: BioDelivery Sciences expects fourth quarter and 2019 total net sales at the high end of guidance
Jan 06, 2020: BioDelivery Sciences appoints Kevin Ostrander as Senior Vice President of Business Development

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

BioDelivery Sciences International Inc, Key Facts
BioDelivery Sciences International Inc, Key Employees
BioDelivery Sciences International Inc, Key Employee Biographies
BioDelivery Sciences International Inc, Major Products and Services
BioDelivery Sciences International Inc, History
BioDelivery Sciences International Inc, Subsidiaries
BioDelivery Sciences International Inc, Key Competitors
BioDelivery Sciences International Inc, Ratios based on current share price
BioDelivery Sciences International Inc, Annual Ratios
BioDelivery Sciences International Inc, Annual Ratios (Cont...1)
BioDelivery Sciences International Inc, Annual Ratios (Cont...2)
BioDelivery Sciences International Inc, Interim Ratios
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioDelivery Sciences International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

BioDelivery Sciences International Inc, Performance Chart (2016 - 2020)
BioDelivery Sciences International Inc, Ratio Charts
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021